105 related articles for article (PubMed ID: 34621334)
1. Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India.
Manjhi PK; Kumar R; Priya A; Rab I
Maedica (Bucur); 2021 Jun; 16(2):163-169. PubMed ID: 34621334
[No Abstract] [Full Text] [Related]
2. Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management.
Mahboobipour AA; Baniasadi S
Drug Metab Pers Ther; 2020 Dec; ():. PubMed ID: 33580642
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic Strategies in Invasively Managed Patients with Non-ST Elevation Acute Coronary Syndromes and Non-Valvular Atrial Fibrillation in Romania.
Cotoban AG; Udroiu CA; Vina R; Vinereanu D
Maedica (Bucur); 2021 Mar; 16(1):6-15. PubMed ID: 34221150
[No Abstract] [Full Text] [Related]
4. Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients.
Kilit TP; Özyiğit F; Erarslan S; Onbaşı K
Afr Health Sci; 2022 Dec; 22(4):597-606. PubMed ID: 37092113
[TBL] [Abstract][Full Text] [Related]
5. Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study.
Turner RM; de Koning EM; Fontana V; Thompson A; Pirmohamed M
BMC Med; 2020 Nov; 18(1):367. PubMed ID: 33234119
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases.
Meakleartmongkol T; Tangpanithandee S; Vanavivit N; Jiso A; Pongchaikul P; Kirdlarp S; Khemawoot P; Nathisuwan S
PLoS One; 2023; 18(11):e0293866. PubMed ID: 37972000
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation.
González-Pacheco H; Márquez MF; Arias-Mendoza A; Álvarez-Sangabriel A; Eid-Lidt G; González-Hermosillo A; Azar-Manzur F; Altamirano-Castillo A; Briseño-Cruz JL; García-Martínez A; Mendoza-García S; Martínez-Sánchez C
J Cardiol; 2015 Aug; 66(2):148-54. PubMed ID: 25480145
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
11. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
12. Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study.
Zhao M; Liu CF; Feng YF; Chen H
Front Pharmacol; 2022; 13():946415. PubMed ID: 36091832
[No Abstract] [Full Text] [Related]
13. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
[TBL] [Abstract][Full Text] [Related]
16. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
17. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
Yang Q; Wang Y; Liu J; Liu J; Hao Y; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Wang W; Zhou Y; Zhao D;
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28606999
[TBL] [Abstract][Full Text] [Related]
18. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
20. Clinically important drug-drug interactions in primary care.
Dhabali AA; Awang R; Zyoud SH
J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
